BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16122714)

  • 21. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice.
    Luszczki JJ; Mohamed M; Czuczwar SJ
    Eur J Pharmacol; 2006 Feb; 531(1-3):66-73. PubMed ID: 16403497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of phenytoin and phenobarbital on seizures induced by imipenem/cilastatin in rats.
    Zivanovic D; Stanojlovic O; Susic V; Stojanovic J
    Acta Neurol Belg; 2004 Mar; 104(1):20-6. PubMed ID: 15143958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential hippocampal pharmacokinetics of phenobarbital and carbamazepine in repetitive seizures induced by 3-mercaptopropionic acid.
    Höcht C; Lazarowski A; Gonzalez NN; Mayer MA; Opezzo JA; Taira CA; Girardi E
    Neurosci Lett; 2009 Mar; 453(1):54-7. PubMed ID: 19429015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticonvulsant effects of carbamazepine on spontaneous seizures in rats with kainate-induced epilepsy: comparison of intraperitoneal injections with drug-in-food protocols.
    Grabenstatter HL; Clark S; Dudek FE
    Epilepsia; 2007 Dec; 48(12):2287-95. PubMed ID: 17711461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imperatorin enhances the protective activity of conventional antiepileptic drugs against maximal electroshock-induced seizures in mice.
    Luszczki JJ; Glowniak K; Czuczwar SJ
    Eur J Pharmacol; 2007 Nov; 574(2-3):133-9. PubMed ID: 17651727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of kainic acid-induced seizure-like activity by antiepileptic drugs.
    Kleinrok Z; Czuczwar SJ; Turski L
    Pol J Pharmacol Pharm; 1980; 32(3):261-9. PubMed ID: 6792611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An experimental evaluation of anticonvulsant activity of Vitex-negundo.
    Tandon VR; Gupta RK
    Indian J Physiol Pharmacol; 2005 Apr; 49(2):199-205. PubMed ID: 16170989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of kainic acid-induced changes in nitric oxide level and neuronal cell damage in the rat hippocampus by manganese complexes of curcumin and diacetylcurcumin.
    Sumanont Y; Murakami Y; Tohda M; Vajragupta O; Watanabe H; Matsumoto K
    Life Sci; 2006 Mar; 78(16):1884-91. PubMed ID: 16266725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the anticonvulsant profile of isonicotinic acid benzylamide in various experimental seizure models in mice.
    Luszczki JJ; Swiader MJ; Swiader K; Paruszewski R; Turski WA; Czuczwar SJ
    Neurosci Lett; 2007 Jun; 421(1):87-90. PubMed ID: 17548162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y.
    Meurs A; Clinckers R; Ebinger G; Michotte Y; Smolders I
    Eur J Neurosci; 2007 Dec; 26(11):3079-92. PubMed ID: 18005069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats.
    Brandt C; Gastens AM; Sun Mz; Hausknecht M; Löscher W
    Neuropharmacology; 2006 Sep; 51(4):789-804. PubMed ID: 16806297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective effect of (R, S)-4-phosphonophenylglycine against neuronal damage associated with homocysteic acid-induced seizures in immature rats.
    Langmeier M; Folbergrová J; Haugvicová R; Riljak V
    Prague Med Rep; 2006; 107(4):421-32. PubMed ID: 17402555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice.
    Donato Di Paola E; Gareri P; Davoli A; Gratteri S; Scicchitano F; Naccari C; De Sarro G
    Epilepsy Res; 2007 Jul; 75(2-3):112-21. PubMed ID: 17553669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological agents, hippocampal EEG, and anticonvulsant effects on soman-induced seizures in rats.
    Myhrer T; Skymoen LR; Aas P
    Neurotoxicology; 2003 Jun; 24(3):357-67. PubMed ID: 12782101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain.
    Kim JS; Kondratyev A; Tomita Y; Gale K
    Epilepsia; 2007; 48 Suppl 5():19-26. PubMed ID: 17910577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticonvulsant effect of eslicarbazepine acetate (BIA 2-093) on seizures induced by microperfusion of picrotoxin in the hippocampus of freely moving rats.
    Sierra-Paredes G; Núñez-Rodriguez A; Vázquez-López A; Oreiro-García T; Sierra-Marcuño G
    Epilepsy Res; 2006 Dec; 72(2-3):140-6. PubMed ID: 16920333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nefiracetam activation of CaM kinase II and protein kinase C mediated by NMDA and metabotropic glutamate receptors in olfactory bulbectomized mice.
    Moriguchi S; Han F; Shioda N; Yamamoto Y; Nakajima T; Nakagawasai O; Tadano T; Yeh JZ; Narahashi T; Fukunaga K
    J Neurochem; 2009 Jul; 110(1):170-81. PubMed ID: 19457128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cognition-enhancer nefiracetam inhibits both necrosis and apoptosis in retinal ischemic models in vitro and in vivo.
    Ueda M; Fujita R; Koji T; Ueda H
    J Pharmacol Exp Ther; 2004 Apr; 309(1):200-7. PubMed ID: 14718588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection against kainate neurotoxicity by ginsenosides: attenuation of convulsive behavior, mitochondrial dysfunction, and oxidative stress.
    Shin EJ; Jeong JH; Kim AY; Koh YH; Nah SY; Kim WK; Ko KH; Kim HJ; Wie MB; Kwon YS; Yoneda Y; Kim HC
    J Neurosci Res; 2009 Feb; 87(3):710-22. PubMed ID: 18816793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of the antiepileptic drug ethosuximide on G protein-activated inwardly rectifying K+ channels.
    Kobayashi T; Hirai H; Iino M; Fuse I; Mitsumura K; Washiyama K; Kasai S; Ikeda K
    Neuropharmacology; 2009 Feb; 56(2):499-506. PubMed ID: 18977371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.